Comparative analysis of CA 242 and CA 19-9 serum tumor markers in colorectal cancer patients. A longitudinal evaluation

Anticancer Research

Volumn 21, Issue 2 B, 2001, Pages 1263-1270

  Spila, A ^a   Ferroni, P ^a   Cosimelli, M ^a   D'Alessandro, R ^a   Abbolito, M R ^a   Mariotti, S ^a   Aloe, S ^a   Carone, M D ^a   Graziano, F ^a   Tedesco, M ^a   Martini, F ^a   Mancini, R ^a   Stigliano, V ^a   Roselli, M ^a   Guadagni, F ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

CA 19 9; CA 242; Carcinoembryonic antigen; Colorectal cancer; Serum tumor markers

Indexed keywords

CA 19-9 ANTIGEN; CA 242 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; TUMOR MARKER;

ADULT; ARTICLE; CANCER PATIENT; CANCER RECURRENCE; CLINICAL TRIAL; COLORECTAL CANCER; COMPARATIVE STUDY; CORRELATION FUNCTION; DISEASE MARKER; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MACROMOLECULE; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED;

EID: 0035024861     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. The preoperative carcinoembryonic test in the diagnosis, staging and prognosis of colorectal cancer
2. Clinical applications of carcinoembryonic antigen
3. TAG-72 (CA 72-4 assay) as a complementary serum tumor antigen to carcinoembryonic antigen in monitoring patients with colorectal cancer
4. Sensitivity and specificity of CA 242 in gastro-intestinal cancer. A comparison with CEA, CA50 and CA 19-9
5. Comparison of a new tumour marker CA 242 with CA 19-9, CA 50 and carcinoembryonic antigen (CEA) in digestive tract diseases
6. The role of CA 242 and CEA in surveillance following curative resection for colorectal cancer
7. Preoperative serum levels of CEA and CA 242 in colorectal cancer
8. Comparative evaluation of four tumor markers, CA 242, CA 19-9, TPA, and CEA in carcinomas of the colon
9. Evaluation of the CA 242 tumor antigen as a potential serum marker for colorectal cancer
10. Monoclonal antibody detection of a circulating tumor-associated antigen. I. Presence of antigen in sera of patients with colorectal, gastric and pancreatic carcinoma
11. CA 72-4 measurement of tumor-associated glycoprotein-72 (TAG-72) as a serum marker in the management of gastric carcinoma
12. Correlation between positive CA 72-4 serum levels and lymph node involvement in patients with gastric cancer
13. The association of preoperative serum tumour markers with Dukes' stage and survival in colorectal cancer
14. Preoperative serum levels of CA 242 and CEA predict outcome in colorectal cancer
15. Independent prognostic value of preoperative serum markers CA 242, specific tissue polypeptide antigen and human chorionic gonadotrophin beta, but not of carcinoembryonic antigen or tissue polypeptide antigen in colorectal cancer
16. The use of tumour markers CEA, CA-195 and CA-242 in evaluating the response to chemotherapy in patients with advanced colorectal cancer
17. The role of CA 242 and CEA in surveillance following curative resection for colorectal cancer
18. Serum CA 242 and CEA detect different patients with recurrent colorectal cancer
19. Is CA 242 really a new tumor marker for pancreatic adenocarcinoma?
20. Purification and characterization of a membrane-bound and a secreted mucin-type glycoprotein carrying the carcinoma associated sialyl-Lea epitope on distinct core proteins
21. Comparison of serological expression of different epitopes on the CA 50-carrying antigen CanAg
22. Novel epitopes on the CA 50-carrying antigen: Chemical and immunochemical studies
23. Role of tumor markers, cytogenetics
24. The use of CEA as an early indicator for gastrointestinal tumor recurrence and second-look procedures